Detalhe da pesquisa
1.
A multiyear systematic survey of the quality of reporting for randomised trials in dentistry, neurology and geriatrics published in journals of Spain and Latin America.
BMC Med Res Methodol
; 21(1): 153, 2021 07 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-34311704
2.
SARS-CoV-2 humoral immune response in patients with cardiovascular risk factors: The COmmunity Cohort Study. / Respuesta inmune humoral por exposición a antígenos de SARS-CoV-2 en adultos con riesgo cardiovascular: The COmmunity Cohort.
Medwave
; 23(11): e2787, 2023 Dec 20.
Artigo
em Inglês, Espanhol
| MEDLINE | ID: mdl-38117982
3.
Exploring physicians' perception of diagnostic information in clinical practice.
Medwave
; 23(1): e2665, 2023 Feb 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-36820833
4.
Humoral and cellular response induced by a second booster of an inactivated SARS-CoV-2 vaccine in adults.
EBioMedicine
; 91: 104563, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-37099842
5.
Respondent-driven sampling: Advantages and disadvantages from a sampling method. / Respondent-driven sampling: ventajas e inconvenientes de un método de muestreo.
Medwave
; 21(1): e8513, 2022 Jan 03.
Artigo
em Espanhol, Inglês
| MEDLINE | ID: mdl-34979532
6.
SARS-CoV-2 humoral immune response in patients with cardiovascular risk factors: the COmmunity Cohort Study protocol.
BMJ Open
; 12(5): e061345, 2022 05 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-35589344
7.
A booster dose of an inactivated SARS-CoV-2 vaccine increases neutralizing antibodies and T cells that recognize Delta and Omicron variants of concern.
medRxiv
; 2022 Feb 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35441179
8.
Differences in the immune response elicited by two immunization schedules with an inactivated SARS-CoV-2 vaccine in a randomized phase 3 clinical trial.
Elife
; 112022 10 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-36226829
9.
A Booster Dose of CoronaVac Increases Neutralizing Antibodies and T Cells that Recognize Delta and Omicron Variants of Concern.
mBio
; 13(4): e0142322, 2022 08 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-35946814
10.
Immune Profile and Clinical Outcome of Breakthrough Cases After Vaccination With an Inactivated SARS-CoV-2 Vaccine.
Front Immunol
; 12: 742914, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34659237
11.
Quality of reporting for randomised clinical trials published in Latin American and Spanish journals: A protocol for a systematic survey of three clinical specialities.
BMJ Open
; 10(6): e036148, 2020 06 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-32565468
12.
Author misrepresentation of institutional affiliations: protocol for an exploratory case study.
BMJ Open
; 9(2): e023983, 2019 02 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-30798307
13.
Respuesta inmune humoral por exposición a antígenos de SARS-CoV-2 en adultos con riesgo cardiovascular: The COmmunity Cohort / SARS-CoV-2 humoral immune response in patients with cardiovascular risk factors: The COmmunity Cohort Study
Medwave
; 23(11): e2787, 31-12-2023.
Artigo
em Inglês, Espanhol
|
LILACS-Express
| ID: biblio-1524727
14.
Exploring physicians' perception of diagnostic information in clinical practice / Exploración de la percepción de los médicos sobre la información diagnóstica en la práctica clínica
Medwave
; 23(1): e2665, 28-02-2023.
Artigo
em Inglês
|
LILACS-Express
| ID: biblio-1419214
15.
Potential effectiveness of copper surfaces in reducing health care-associated infection rates in a pediatric intensive and intermediate care unit: A nonrandomized controlled trial.
Am J Infect Control
; 44(8): e133-9, 2016 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27318524
16.
Copper surfaces are associated with significantly lower concentrations of bacteria on selected surfaces within a pediatric intensive care unit.
Am J Infect Control
; 44(2): 203-9, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26553403
17.
Common statistical misconceptions-plainly explained. / Common statistical misconceptions-plainly explained.
Medwave
; 19(6): e7660, 2019 Jul 02.
Artigo
em Espanhol, Inglês
| MEDLINE | ID: mdl-31348772
18.
[Incidence of severe rotavirus gastroenteritis among Chilean children under three years of age]. / Impacto de gastroenteritis severa por rotavirus en niños chilenos menores de 3 años de edad.
Rev Med Chil
; 135(8): 975-81, 2007 Aug.
Artigo
em Espanhol
| MEDLINE | ID: mdl-17989853
19.
[Potential cost effectiveness of a rotavirus vaccine in Chile]. / Evaluaciónde costo-efectividad de la vacuna anti-rotavirus en Chile.
Rev Med Chil
; 134(6): 679-88, 2006 Jun.
Artigo
em Espanhol
| MEDLINE | ID: mdl-17130941
20.
Cost-effectiveness of universal childhood hepatitis A vaccination in Chile.
Vaccine
; 23(32): 4110-9, 2005 Jul 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-15964479